Phosphodiesterases and cyclic GMP regulation in heart muscle.
about
Targeting myocardial remodelling to develop novel therapies for heart failure: a position paper from the Working Group on Myocardial Function of the European Society of CardiologyTreatment-related biomarkers in pulmonary hypertensionSex, drugs, and trial design: sex influences the heart and drug responsesCa²+/calmodulin-dependent protein kinase II (CaMKII) activity and sinoatrial nodal pacemaker cell energetics.Right ventricular cyclic nucleotide signaling is decreased in hyperoxia-induced pulmonary hypertension in neonatal mice.Phenotype-Specific Treatment of Heart Failure With Preserved Ejection Fraction: A Multiorgan Roadmap.Chemotherapeutic efficacy of phosphodiesterase inhibitors in chagasic cardiomyopathy.PDE1C deficiency antagonizes pathological cardiac remodeling and dysfunction.Genetically altered mutant mouse models of guanylyl cyclase/natriuretic peptide receptor-A exhibit the cardiac expression of proinflammatory mediators in a gene-dose-dependent manner.Role of sGC-dependent NO signalling and myocardial infarction risk.Protein kinase G signaling in cardiac pathophysiology: Impact of proteomics on clinical trials.Therapeutic Targeting of PDEs and PI3K in Heart Failure with Preserved Ejection Fraction (HFpEF).Saxagliptin and Tadalafil Differentially Alter Cyclic Guanosine Monophosphate (cGMP) Signaling and Left Ventricular Function in Aortic-Banded Mini-Swine.Phosphodiesterase 1: A Unique Drug Target for Degenerative Diseases and Cognitive Dysfunction.Rho kinase mediates right ventricular systolic dysfunction in rats with chronic neonatal pulmonary hypertension.Imaging of PDE2- and PDE3-Mediated cGMP-to-cAMP Cross-Talk in Cardiomyocytes.Functional β2-adrenoceptors in rat left atria: effect of foot-shock stress.cGMP Signaling in the Cardiovascular System-The Role of Compartmentation and Its Live Cell Imaging.
P2860
Q27024879-3AA30B5C-2BD8-4E96-9A33-E7A94D545986Q28081276-824730F0-342E-4F45-B779-F8E71869DC3BQ33872473-C881B0D4-F234-4BFB-AE76-0A29580B2DE2Q34607888-3321425B-49BC-404C-A244-899FF8B90058Q35749616-C54D401D-932A-4831-8492-101254C6F814Q37058596-B5BF79DC-C05D-4EE6-AE9F-0E88400E9C99Q37341337-EA6182CF-BA48-409F-A4B7-6D64821EE279Q37417757-0B8E4BE0-21BB-4C6B-A514-BEBCC5024D9AQ37594085-A9F7F74E-1484-4426-802D-1080E1C70C0FQ38367012-85D7B409-ED43-4325-BD18-EBD4F1B64B0FQ38670275-1A41450B-47EA-4CDE-861A-80EB7AA32CB9Q39268911-157B2FA8-E958-413A-9595-C21F8BD48BD6Q40580301-7FCA83C0-D7C1-42B9-85BB-F82E85B228BEQ42515895-0D67EC9B-8979-43E2-BBB6-B0F16E3C52B8Q44589946-C7EDB2E4-4E09-48BA-B8F8-EC3CBCDED45FQ49787366-67CF0DFE-D914-445A-9232-1E39D0D78BCAQ51825605-FE839E8D-306C-4FA4-9D9B-4CD9BD5F283BQ55004774-0FF4F32F-C76D-4295-BBED-C885670D4281
P2860
Phosphodiesterases and cyclic GMP regulation in heart muscle.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Phosphodiesterases and cyclic GMP regulation in heart muscle.
@en
type
label
Phosphodiesterases and cyclic GMP regulation in heart muscle.
@en
prefLabel
Phosphodiesterases and cyclic GMP regulation in heart muscle.
@en
P2860
P1433
P1476
Phosphodiesterases and cyclic GMP regulation in heart muscle.
@en
P2093
David A Kass
Dong I Lee
P2860
P304
P356
10.1152/PHYSIOL.00011.2012
P577
2012-08-01T00:00:00Z